دانلود رایگان مقاله لاتین گیاه ساخته شده ایمونوتراپوتیک از سایت الزویر


عنوان فارسی مقاله:

موردی برای گیاه ساخته شده ایمونوتراپوتیک دامپزشکی


عنوان انگلیسی مقاله:

The case for plant-made veterinary immunotherapeutics


سال انتشار : 2016



برای دانلود رایگان مقاله گیاه ساخته شده ایمونوتراپوتیک اینجا کلیک نمایید.





بخشی از مقاله انگلیسی :


Animal diseases have both direct costs — the immediate impact on livestock populations and agriculture — and indirect costs, such as mitigation or control efforts, losses in trade and other revenues, and impacts on human health. Zoonotic diseases are estimated to cause 75% of new emerging human infections, thus leading to significant morbidity and mortality, and creating costs in labor markets due to reduced trade and control measures. Diseases without zoonotic potential also impact human welfare costs through instability and increases in the cost of food. For example, the most recent estimate made in 2007 by the World Organization for Animal Health (OIE) of the direct impact of avian flu alone is $43 billion annually, while indirect costs are expected to be around $1.5 trillion [(The World Organisation for Animal Health, 2007), and tables 24–25 therein]. A variety of interventions can be used to combat bacterial (and viral) disease in animals, each with its own advantages and disadvantages (Table 1). Of the available alternatives to antibiotics, vaccination is likely the most widely used and effective strategy. Vaccination against viruses can also contribute to lower therapeutic use of antibiotics by reducing the incidence of secondary infections (Glass-Kaastra et al., 2013). Yet, vaccines and immunotherapeutics are available for only a limited number of animal diseases; and while global sales of animal health products in 2013 were $23 billion, only $5 billion corresponded to veterinary vaccines (Dolcera, 2014; Health for Animals, 2014).



برای دانلود رایگان مقاله گیاه ساخته شده ایمونوتراپوتیک اینجا کلیک نمایید.






کلمات کلیدی:

The case for plant-made veterinary immunotherapeutics. - NCBI https://www.ncbi.nlm.nih.gov/pubmed/26875776 by E Topp - ‎2016 - ‎Cited by 3 - ‎Related articles Feb 12, 2016 - The case for plant-made veterinary immunotherapeutics. Topp E(1), Irwin R(2), McAllister T(3), Lessard M(4), Joensuu JJ(5), Kolotilin I(6), ... Plant-based solutions for veterinary immunotherapeutics and ... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280687/ by I Kolotilin - ‎2014 - ‎Cited by 22 - ‎Related articles Dec 31, 2014 - Glycoengineering. 5.3. Vaccine bioencapsulation and delivery. 5.4. Scale-up and speed. Examples of therapeutic proteins produced in plants. The case for plant-made veterinary immunotherapeutics — Arizona ... https://asu.pure.elsevier.com/.../the-case-for-plant-made-veterinary-immunotherapeuti... by E Topp - ‎2015 - ‎Cited by 3 - ‎Related articles Sep 29, 2015 - The case for plant-made veterinary immunotherapeutics. Edward Topp, Rebecca Irwin, Tim McAllister, Martin Lessard, Jussi J. Joensuu, Igor ... [PDF]The case for plant-made veterinary immunotherapeutics iranarze.ir/wp-content/uploads/2016/10/E472.pdf The case for plant-made veterinary immunotherapeutics☆. Edward Topp a, Rebecca Irwin b, Tim McAllister c, Martin Lessard d, Jussi J. Joensuu e, Igor Kolotilin ... The case for plant-made veterinary immunotherapeutics. - Agriculture ... www.agr.gc.ca/eng/abstract/publication?id=37315000000610 Feb 17, 2016 - "The case for plant-made veterinary immunotherapeutics.", Biotechnology Advances. doi : 10.1016/j.biotechadv.2016.02.007 Access to full text ... The case for plant-made veterinary immunotherapeutics - Biblio UGent https://biblio.ugent.be/publication/8113166 by E Topp - ‎2016 - ‎Cited by 3 - ‎Related articles Oct 13, 2016 - The case for plant-made veterinary immunotherapeutics. Edward Topp, Rebecca Irwin, Tim McAllister, Martin Lessard, Jussi J Joensuu, Igor ... The case for plant-made veterinary immunotherapeutics - Biblio UGent https://biblio.ugent.be/publication/8509406 by E Topp - ‎2016 - ‎Cited by 3 - ‎Related articles Feb 14, 2017 - The case for plant-made veterinary immunotherapeutics. Edward Topp, Rebecca Irwin, Tim McAllister, Martin Lessard, Jussi J. Joensuu, Igor ... [PDF]Mission Report - OECD www.oecd.org/.../Plant-made-Vaccines-as-alternatives-to-Antibiotics_Organisers'-Rep... “Plant-made vaccines and immunotherapeutic agents as alternatives to veterinary antibiotics: countering antibiotic resistance and ensuring human food safety”. Literature | The International Society for Plant Molecular Farming societyformolecularfarming.org/node/24 Plant Sci. 7, 18. Molecular pharming-VLPs made in plants, Marsian, J. and ... The case for plant-made veterinary immunotherapeutics, Topp, E. et al. Biotechnol ...